Showing results (2521-2530 of 2,668) with videos related to

Sort By:
Pageof 267
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 4, 2021
Sensitivity analysis of the primary endpoint from the N-MOmentum study of inebilizumab in NMOSDBruce Ac Cree, Jeffrey L Bennett, Ho Jin Kim, et al.
Annals of Neurology|May 4, 2004
SIMPLE mutation in demyelinating neuropathy and distribution in sciatic nerveCraig L Bennett, Andrew J Shirk, Huy M Huynh, et al.
Cancer|April 29, 2014
Progressive multifocal leukoencephalopathy associated with brentuximab vedotin therapy: a report of 5 cases from the Southern Network on Adverse Reactions (SONAR) projectKenneth R Carson, Scott D Newsome, Ellen J Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2014
Systemic therapy in men with metastatic castration-resistant prostate cancer:American Society of Clinical Oncology and Cancer Care Ontario clinical practice guidelineEthan Basch, D Andrew Loblaw, Thomas K Oliver, et al.
Theriogenology|November 4, 2022
Polymorphism of the follicle stimulating hormone receptor does not impact reproductive performance or in-vitro embryo production in beef heifersAlexandria P Snider, Hannah K Yake, Camryn D Granger, et al.
The Journal of Clinical Investigation|February 28, 2018
Redirection to the bone marrow improves T cell persistence and antitumor functionsAnjum B Khan, Ben Carpenter, Pedro Santos E Sousa, et al.
The Journal of Cell Biology|October 11, 2017
LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent late endosomal positioningPrzemyslaw A Filipek, Mariana E G de Araujo, Georg F Vogel, et al.
Nature|January 7, 2015
SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1Manuele Rebsamen, Lorena Pochini, Taras Stasyk, et al.
The Lancet. Neurology|January 27, 2023
Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteriaBrenda Banwell, Jeffrey L Bennett, Romain Marignier, et al.
JCI Insight|April 25, 2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survivalMaria V Guijarro, Patrick C Kellish, Peter E Dib, et al.
Pageof 267